Search by Drug Name or NDC
NDC 76045-0101-20 Metoclopramide 10 mg/2mL Details
Metoclopramide 10 mg/2mL
Metoclopramide is a INTRAMUSCULAR; INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is METOCLOPRAMIDE HYDROCHLORIDE.
MedlinePlus Drug Summary
Metoclopramide injection is used to relieve symptoms caused by slow stomach emptying in people who have diabetes. These symptoms include nausea, vomiting, heartburn, loss of appetite, and feeling of fullness that lasts long after meals. Metoclopramide injection is also used to prevent nausea and vomiting caused by chemotherapy or that may occur after surgery. Metoclopramide injection is also sometimes used to empty the intestines during certain medical procedures. Metoclopramide injection is in a class of medications called prokinetic agents. It works by speeding the movement of food through the stomach and intestines.
Related Packages: 76045-0101-20Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Metoclopramide Injection
Product Information
| NDC | 76045-0101 |
|---|---|
| Product ID | 76045-101_4a411ded-d608-41d3-bb26-67d5d5d3c9b5 |
| Associated GPIs | 52300020102005 |
| GCN Sequence Number | 023581 |
| GCN Sequence Number Description | metoclopramide HCl SYRINGE 10 MG/2 ML INJECTION |
| HIC3 | J9A |
| HIC3 Description | INTESTINAL MOTILITY STIMULANTS |
| GCN | 20512 |
| HICL Sequence Number | 002148 |
| HICL Sequence Number Description | METOCLOPRAMIDE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Metoclopramide |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Metoclopramide Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAMUSCULAR; INTRAVENOUS |
| Active Ingredient Strength | 10 |
| Active Ingredient Units | mg/2mL |
| Substance Name | METOCLOPRAMIDE HYDROCHLORIDE |
| Labeler Name | Fresenius Kabi USA, LLC |
| Pharmaceutical Class | Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA091392 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 76045-0101-20 (76045010120)
| NDC Package Code | 76045-101-20 |
|---|---|
| Billing NDC | 76045010120 |
| Package | 24 BLISTER PACK in 1 CARTON (76045-101-20) / 1 SYRINGE, GLASS in 1 BLISTER PACK (76045-101-00) / 2 mL in 1 SYRINGE, GLASS |
| Marketing Start Date | 2013-05-03 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |